Provided by Tiger Trade Technology Pte. Ltd.

Beta Bionics, Inc.

19.23
+2.5014.94%
Post-market: 18.11-1.1201-5.82%19:58 EDT
Volume:1.70M
Turnover:31.63M
Market Cap:856.92M
PE:-11.66
High:19.55
Open:16.73
Low:16.37
Close:16.73
52wk High:32.71
52wk Low:8.80
Shares:44.56M
Float Shares:24.29M
Volume Ratio:1.62
T/O Rate:7.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6486
EPS(LYR):-1.8100
ROE:-26.16%
ROA:-16.67%
PB:3.34
PE(LYR):-10.62

Loading ...

Beta Bionics Inc Outlook FY Revenue USD 131-136 Million

THOMSON REUTERS
·
Jul 30

Beta Bionics Inc Q2 EPS USD -0.53

THOMSON REUTERS
·
Jul 30

Press Release: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance

Dow Jones
·
Jul 30

Beta Bionics Coverage Assumed by UBS at Buy

Dow Jones
·
Jul 29

UBS Adjusts Price Target on Beta Bionics to $22 From $24, Maintains Buy Rating

MT Newswires Live
·
Jul 28

Beta Bionics resumed with a Buy at UBS

TIPRANKS
·
Jul 28

Here's Why We're Not Too Worried About Beta Bionics' (NASDAQ:BBNX) Cash Burn Situation

Simply Wall St.
·
Jul 28

Beta Bionics is Maintained at Buy by Goldman Sachs

Dow Jones
·
Jul 16

Beta Bionics is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 14

Beta Bionics price target raised to $22 from $18 at Truist

TIPRANKS
·
Jul 13

Truist Raises Price Target on Beta Bionics to $22 From $18, Keeps Buy Rating

MT Newswires Live
·
Jul 13

Beta Bionics Schedules Q2 2026 Results Webcast and Conference Call

Reuters
·
Jul 01

Beta Bionics CFO Stephen Feider Disposes of USD 173,083.32 in Common Shares

Reuters
·
Jul 01

Beta Bionics Director Christy Jones Sells 1,406 Shares for $21,090

Reuters
·
Jun 26

Beta Bionics Chief Commercial Officer Mark Hopman disposes of 275 common shares for $3,385.25

Reuters
·
Jun 06

Beta Bionics director Christy Jones sells 2,811 shares worth $39,354

Reuters
·
Jun 06

Beta Bionics management to meet with Piper Sandler

TIPRANKS
·
Jun 04

Beta Bionics launches public near real-time real-world iLet Bionic Pancreas outcomes dashboard

Reuters
·
Jun 02

Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website

GlobeNewswire
·
Jun 02

Beta Bionics Is Maintained at Buy by Goldman Sachs

Dow Jones
·
May 28